-
Most Recent
Healthcare Stocks
Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
7 Dependable Dividend Stocks for Long-Term Income
Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.
3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct
These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.
Other industries you might be interested in
Recent Healthcare Stocks Articles
ETF Alternatives for Last Week’s Hot Stocks
Some of InvestorPlace's top stock picks in energy, dividend, pharmaceutical, home furnishings and financial stocks can be wrapped up into exchange-traded funds.
Hospital Stocks Set for Good, Not Great, 2013
Further gains are possible, but not like 2012's terrific performance. Political uncertainty over Medicaid cuts will most likely make for a volatile ride.
Which Abbott Is the One to Own Post-Split?
Both offer good prospects, but if you can choose just one, AbbVie -- which is the device and diagnostics side -- looks a tad more promising than the pharma arm.
Best & Worst Mutual Funds of 2012
Mixed-cap, small-cap and biotech stocks were the places to be in mutual funds this year. But if you went for metals or were generally bearish, you lost out.
Top 10 Dow Dividend Stocks for December
Income investors could do a lot worse than buying into these venerable blue chips, but some only have great yields thanks to a not-so-hot year.
S&P 500 Ends Its Streak — Thursday’s IP Market Recap
The markets ended in the red for the day in the wake of Boehner's fiscal cliff remarks, and in the face of strong retail sales and a sharp slide in jobless claims.
Big Pharma: 2012-13’s Flu Vaccine Field
Here's a look at the various big pharma stocks that could see a bump from an early start to this year's flu season.
Stocks at New Highs, New Lows for 12/4
Get the scoop on today's big moves. See which stock hit a new 52-week high, and one that found a new 52-week low.
Effective Alzheimer’s Drugs May Be Just Three Years Away
New research, both by scientists and the big drug companies, is leading to increased hope for sufferers of Alzheimer's disease.
Biotech Movers: Acadia Rockets on Trial News
Acadia Pharmaceuticals leads the way with a week of eye-popping gains. Plus: Why Exelixis and Supernus took tough tumbles.
‘Boardwalk Empire,’ Obamacare and Healthcare Stocks
The Prohibition era has lessons for today's investors. Soon, Washington will be the only healthcare player in town. That's when you short these stocks.
Biotech Movers: Regeneron Pops, 3 Flop
While Regeneron soared on behind its macular degeneration treatment, Dynavax, Navidea and AspenBio suffered serious setbacks.
Consolidation Provides Good Entry Point for Top Biotech
Gilead Sciences (NASDAQ:GILD) is in an orderly bull market characterized by breakouts followed by short-term consolidations.
4 Attractive Biopharma Stocks of All Sizes
Biopharma is a high-growth niche in a defensive sector, but you need to balance risk with reward. Here are four hot biopharma stocks of different sizes.
My Brilliant Biotech Move for 2012
An overly helter-skelter year in the world of biotech stocks has been a stark reminder of a basic lesson that isn't followed enough: Keep it simple.
Novartis Touts Pipeline of Blockbuster Drugs
Novartis says that it could produce 14 or more top-selling new drugs over the next five years as it expands its pipeline of new medications.
